Raymed Labs Limited reported earnings results for the fourth quarter ended March 31, 2022. For the fourth quarter, the company reported net loss was INR 0.439 million compared to INR 0.479 million a year ago. Basic loss per share from continuing operations was INR 0.103 compared to INR 0.011 a year ago. Diluted loss per share from continuing operations was INR 0.103 compared to INR 0.011 a year ago. Basic loss per share was INR 0.103 compared to INR 0.011 a year ago. Diluted loss per share was INR 0.103 compared to INR 0.011 a year ago.